Histamine inhibits cell proliferation and modulates the expression of Bcl-2 family proteins via the H2 receptor in human pancreatic cancer cells

Anticancer Research

Volumn 26, Issue 6 B, 2006, Pages 4443-4450

  Cricco, Graciela ^a   Martín, Gabriela ^a,c   Medina, Vanina ^a   Núñez, Mariel ^a   Mohamad, Nora ^a   Croci, Máximo ^b   Crescenti, Ernesto ^b   Bergoc, Rosa ^a,c   Rivera, Elena ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Institute of Immunooncology   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Bax; Bcl x; Cell proliferation; Histamine; Pancreatic cancer

Indexed keywords

HISTAMINE; HISTAMINE H2 RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN C FOS; PROTEIN P53;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL GROWTH; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; WESTERN BLOTTING;

CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; HISTAMINE; HUMANS; IMMUNOHISTOCHEMISTRY; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, HISTAMINE H2;

EID: 33845937034     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Lieber M, Mazzeta J, Nelson-Rees W, Kaplan M and Todaro G: Establishment of a continuous tumor-cell line (PANC-1) from a human carcinoma of the exocrine pancreas: Int J Cancer 15: 741-747, 1975.
2. Pós Z, Hegyesi H and Rivera E: Histamine and cell proliferation. In: Histamine: Biology and Medical Aspects. Falus A (ed.). Budapest, SpringMed Publishing, pp. 199-217, 2004.
3. Cricco G, Martín G, Labombarda F, Cocca C, Bergoc R and Rivera E: Human pancreatic carcinoma cell line PANC-1 and the role of histamine on cell growth. Inflamm Res 49: S68-69, 2000.
4. Martín G, Cricco G, Darvas Z, Croci M, Núñez M, Bergoc R, Falus A and Rivera E: Histamine inhibits proliferation of a pancreatic carcinoma cell line without inducing apoptosis significantly. Inflamm Res 51: S67-68, 2002.
5. Oltvai Z, Milliman C and Korsmeyer S: Bcl-2 heterodimerizes in vivo with a conserved homolog Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
6. Hersey P and Zhang X: Overcoming resistance of cancer cells to apoptosis. J Cell Physiol 196: 9-18, 2003.
7. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB and Korsmeyer SJ: Pro-apoptotic Bax and Bak are a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
8. Mohamad N, Cocca C, Núñez M, Gutiérrez A, Martín G, Cricco G, Medina V, Rivera E and Bergoc R: Mitochondrial apoptotic pathways. Biocell 29: 149-161, 2005.
9. Theodorakis P, Lomonosova E and Chinnadurai G: Critical requirement of Bax for manifestation of apoptosis induced by multiple stimuli in human epithelial cancer cells. Cancer Res 62: 3373-3376, 2002.
10. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
11. Singh J, Pariente J and Salido G: The physiological role of histamine in the exocrine pancreas. Inflamm Res 465: 159-165, 1997.
12. 1 receptor expression in human neuroblastoma cell line Paju. Anticancer Res 24: 1657-1664, 2004.
13. Leurs R, Smit M and Timmerman H: Molecular pharmacological aspects of histamine receptors. Phamacol Ther 66: 413-463, 1995.
14. 1 receptors. J Cell Biol 110: 1211-1215, 1990.
15. Rivera E, Cricco G, Engel N, Fitzsimons C, Martín G and Bergoc, R: Histamine as an autocrine growth factor: an unusual role for a widespread mediator. Semin Cancer Biol 10: 15-23, 2000.
16. Lázár-Molnár E, Hegyesi H, Pállinger E, Kovács P, Tóth S, Fitzsimons C, Cricco G, Martín G, Bergoc R, Darvas Z, Rivera E and Falus A: Inhibition of human primary melanoma cell proliferation by histamine is enhanced by interleukin-6. Eur J Clin Invest 32: 743-749, 2002.
17. 2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in culture. Biochem Biophys Res Commun 177: 545-550, 1991.
18. Shimada K, Abe T, Zhao Q, Mio M and Kamei C: Effects of histamine and related compounds on the differentiation of HL-60-Eo cells into eosinophils. Exp Clin Pharmacol 23: 383-388, 2001.
19. 2 receptor in the human promonocytic cell line U937. Mol Pharmacol 51: 983-990, 1997.
20. 2 receptor regulates c-jun and c-fos in a differential manner. Am J Physiol Cell Physiol 278: C1246-C1255, 2000.
21. Ryan KM and Vousden KH: Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol Cell Biol 18: 3692-3698, 1998.
22. 1 histamine receptor antagonist. Oncol Res 14: 363-372, 2004.
23. Hur J, Kang MK, Park JY, Lee SY, Bae YS, Lee SH, Park YM and Kwak JY: Pro-apoptotic effect of high concentrations of histamine on human neutrophils. Int Immunopharmacol 3: 1491-1502, 2005.
24. Kirkin V, Joos S and Zörnig M: The role of Bcl-2 family members in tumorigenesis. Biochem Biophys Acta 1644: 229-249, 2004.
25. Evans J, Cornford P, Dodson A, Greenhalf W, Foster C and Neoptolemos J: Detailed tissue expression of bcl-2, bax, bak and bcl-x in the normal pancreas and in chronic pancreatitis, ampullary and pancreatic ductal adenocarcinomas. Pancreatology 1: 254-262, 2001.
26. Campani D, Esposito I and Boggi U: Bcl-2 expression in pancreas development and pancreatic cancer progression. J Pathol 194: 444-450, 2001.
27. L and Bcl-2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases. Oncogene 21: 7765-7775, 2002.
28. L protects pancreatic adenocarcinoma against CD95 and TRAIL receptor-mediated apoptosis. Oncogene 19: 5477-5486, 2000.
29. Lee J, Hosotani R and Wada M: Role of Bcl-2 family proteins (Bax, Bcl-2 and Bcl-X) on cellular susceptibility to radiation in pancreatic cancer cells. Eur J Cancer 35: 1374-1380, 1999.
30. Boucher M, Duchesne C, Laine J, Morisset J and Rivard N: cAMP protection of pancreatic cancer cells against apoptosis induced by ERK inhibition. Biochem Biophys Res Commun 285: 207-216, 2001.
31. Lindner P, Rizell M, Mattsson J, Hellstrand K, Naredi P: Combined treatment with histamine dihydrochloride, interleukin-2 and interferon-alpha in patients with metastatic melanoma. Anticancer Res 24: 1837-1842, 2004.